Growth differentiation factor-15 (GDF-15) suppresses in vitro angiogenesis through a novel interaction with connective tissue growth factor (CCN2)

Journal of Cellular Biochemistry

Volumn 114, Issue 6, 2013, Pages 1424-1433

  Whitson, Ramon J ^a   Lucia, Marshall Scott ^a   Lambert, James R ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

ANGIOGENESIS; CONNECTIVE TISSUE GROWTH FACTOR (CTGF); Cyr61, CTGF, AND Nov PROTEIN FAMILY 2 (CCN2); FOCAL ADHESION KINASE (FAK); Growth Differentiation Factor 15 (GDF 15); Macrophage Inhibitory Cytokine 1 (MIC 1); Prostate Derived Factor (PDF); Transforming Growth Factor Beta (TGF )

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; GROWTH DIFFERENTIATION FACTOR 15; INTEGRIN; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR TYPE C;

ANGIOGENESIS; ARTICLE; ASSAY; CANCER CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROSTATE CANCER CELL; PROTEIN INTERACTION; UMBILICAL VEIN ENDOTHELIAL CELL; YEAST TWO HYBRID ASSAY;

CELL LINE, TUMOR; CONNECTIVE TISSUE GROWTH FACTOR; FOCAL ADHESION KINASE 1; FOCAL ADHESIONS; GROWTH DIFFERENTIATION FACTOR 15; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTEGRIN ALPHAVBETA3; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 84876239966     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24484     Document Type: Article

References (78)

1. Abreu JG, Ketpura NI, Reversade B, De Robertis EM,. 2002. Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat Cell Biol 4: 599-604.
2. Anthis NJ, Campbell ID,. 2011. The tail of integrin activation. Trends Biochem Sci 36: 191-198.
3. Arnaoutova I, Kleinman HK,. 2010. In vitro angiogenesis: Endothelial cell tube formation on gelled basement membrane extract. Nat Protoc 5: 628-635.
4. Arnaoutova I, George J, Kleinman HK, Benton G,. 2009. The endothelial cell tube formation assay on basement membrane turns 20: State of the science and the art. Angiogenesis 12: 267-274.
5. Auzzas L, Zanardi F, Battistini L, Burreddu P, Carta P, Rassu G, Curti C, Casiraghi G,. 2010. Targeting alphavbeta3 integrin: Design and applications of mono- and multifunctional RGD-based peptides and semipeptides. Curr Med Chem 17: 1255-1299.
6. Babic AM, Kireeva ML, Kolesnikova TV, Lau LF,. 1998. CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc Natl Acad Sci USA 95: 6355-6360.
7. Babic AM, Chen CC, Lau LF,. 1999. Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo. Mol Cell Biol 19: 2958-2966.
8. Baek SJ, Kim KS, Nixon JB, Wilson LC, Eling TE,. 2001. Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities. Mol Pharmacol 59: 901-908.
9. Baek SJ, Okazaki R, Lee SH, Martinez J, Kim JS, Yamaguchi K, Mishina Y, Martin DW, Shoieb A, McEntee MF, Eling TE,. 2006. Nonsteroidal anti-inflammatory drug-activated gene-1 over expression in transgenic mice suppresses intestinal neoplasia. Gastroenterology 131: 1553-1560.
10. Bauskin AR, Zhang HP, Fairlie WD, He XY, Russell PK, Moore AG, Brown DA, Stanley KK, Breit SN,. 2000. The propeptide of macrophage inhibitory cytokine (MIC-1), a TGF-beta superfamily member, acts as a quality control determinant for correctly folded MIC-1. EMBO J 19: 2212-2220.
11. Bauskin AR, Brown DA, Junankar S, Rasiah KK, Eggleton S, Hunter M, Liu T, Smith D, Kuffner T, Pankhurst GJ, Johnen H, Russell PJ, Barret W, Stricker PD, Grygiel JJ, Kench JG, Henshall SM, Sutherland RL, Breit SN,. 2005. The propeptide mediates formation of stromal stores of PROMIC-1: Role in determining prostate cancer outcome. Cancer Res 65: 2330-2336.
12. Bootcov MR, Bauskin AR, Valenzuela SM, Moore AG, Bansal M, He XY, Zhang HP, Donnellan M, Mahler S, Pryor K, Walsh BJ, Nicholson RC, Fairlie WD, Por SB, Robbins JM, Breit SN,. 1997. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci USA 94: 11514-11519.
13. Bottner M, Suter-Crazzolara C, Schober A, Unsicker K,. 1999. Expression of a novel member of the TGF-beta superfamily, growth/differentiation factor-15/macrophage-inhibiting cytokine-1 (GDF-15/MIC-1) in adult rat tissues. Cell Tissue Res 297: 103-110.
14. Brigstock DR,. 2002. Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61). Angiogenesis 5: 153-165.
15. Brigstock DR,. 2003. The CCN family: A new stimulus package. J Endocrinol 178: 169-175.
16. Cekanova M, Lee SH, Donnell RL, Sukhthankar M, Eling TE, Fischer SM, Baek SJ,. 2009. Nonsteroidal anti-inflammatory drug-activated gene-1 expression inhibits urethane-induced pulmonary tumorigenesis in transgenic mice. Cancer Prev Res (Phila) 2: 450-458.
17. Chabut D, Fischer AM, Colliec-Jouault S, Laurendeau I, Matou S, Le Bonniec B, Helley D,. 2003. Low molecular weight fucoidan and heparin enhance the basic fibroblast growth factor-induced tube formation of endothelial cells through heparan sulfate-dependent alpha6 overexpression. Mol Pharmacol 64: 696-702.
18. Chen CC, Lau LF,. 2009. Functions and mechanisms of action of CCN matricellular proteins. Int J Biochem Cell Biol 41: 771-783.
19. Chen CC, Chen N, Lau LF,. 2001. The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts. J Biol Chem 276: 10443-10452.
20. Chen N, Leu SJ, Todorovic V, Lam SC, Lau LF,. 2004. Identification of a novel integrin alphavbeta3 binding site in CCN1 (CYR61) critical for pro-angiogenic activities in vascular endothelial cells. J Biol Chem 279: 44166-44176.
21. Chien W, O'Kelly J, Lu D, Leiter A, Sohn J, Yin D, Karlan B, Vadgama J, Lyons KM, Koeffler HP,. 2011. Expression of connective tissue growth factor (CTGF/CCN2) in breast cancer cells is associated with increased migration and angiogenesis. Int J Oncol 38: 1741-1747.
22. Chu CY, Chang CC, Prakash E, Kuo ML,. 2008. Connective tissue growth factor (CTGF) and cancer progression. J Biomed Sci 15: 675-685.
23. Desgrosellier JS, Cheresh DA,. 2010. Integrins in cancer: Biological implications and therapeutic opportunities. Nat Rev Cancer 10: 9-22.
24. Desgrosellier JS, Barnes LA, Shields DJ, Huang M, Lau SK, Prevost N, Tarin D, Shattil SJ, Cheresh DA,. 2009. An integrin alpha(v)beta(3)-c-Src oncogenic unit promotes anchorage-independence and tumor progression. Nat Med 15: 1163-1169.
25. Dhar A, Ray A,. 2010. The CCN family proteins in carcinogenesis. Exp Oncol 32: 2-9.
26. Ferrari N, Pfeffer U, Dell'Eva R, Ambrosini C, Noonan DM, Albini A,. 2005. The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide. Clin Cancer Res 11: 4610-4619.
27. Folkman J,. 1995. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27-31.
28. Gilbert MR, Kuhn J, Lamborn KR, Lieberman F, Wen PY, Mehta M, Cloughesy T, Lassman AB, Deangelis LM, Chang S, Prados M,. 2012. Cilengitide in patients with recurrent glioblastoma: The results of NABTC 03-02, a phase II trial with measures of treatment delivery. J Neurooncol 106: 147-153.
29. Hanahan D, Weinberg RA,. 2000. The hallmarks of cancer. Cell 100: 57-70.
30. Hayes VM, Severi G, Southey MC, Padilla EJ, English DR, Hopper JL, Giles GG, Sutherland RL,. 2006. Macrophage inhibitory cytokine-1 H6D polymorphism, prostate cancer risk, and survival. Cancer Epidemiol Biomarkers Prev 15: 1223-1225.
31. Heng EC, Huang Y, Black SA, Jr., Trackman PC,. 2006. CCN2, connective tissue growth factor, stimulates collagen deposition by gingival fibroblasts via module 3 and alpha6- and beta1 integrins. J Cell Biochem 98: 409-420.
32. Hromas R, Hufford M, Sutton J, Xu D, Li Y, Lu L,. 1997. PLAB, a novel placental bone morphogenetic protein. Biochim Biophys Acta 1354: 40-44.
33. Huttenlocher A, Horwitz AR,. 2011. Integrins in cell migration. Cold Spring Harb Perspect Biol 3: a005074.
34. James P, Halladay J, Craig EA,. 1996. Genomic libraries and a host strain designed for highly efficient two-hybrid selection in yeast. Genetics 144: 1425-1436.
35. Jedsadayanmata A, Chen CC, Kireeva ML, Lau LF, Lam SC,. 1999. Activation-dependent adhesion of human platelets to Cyr61 and Fisp12/mouse connective tissue growth factor is mediated through integrin alpha(IIb)beta(3). J Biol Chem 274: 24321-24327.
36. Jockusch BM, Bubeck P, Giehl K, Kroemker M, Moschner J, Rothkegel M, Rudiger M, Schluter K, Stanke G, Winkler J,. 1995. The molecular architecture of focal adhesions. Annu Rev Cell Dev Biol 11: 379-416.
37. Karan D, Chen SJ, Johansson SL, Singh AP, Paralkar VM, Lin MF, Batra SK,. 2003. Dysregulated expression of MIC-1/PDF in human prostate tumor cells. Biochem Biophys Res Commun 305: 598-604.
38. Kempf T, Zarbock A, Widera C, Butz S, Stadtmann A, Rossaint J, Bolomini-Vittori M, Korf-Klingebiel M, Napp LC, Hansen B, Kanwischer A, Bavendiek U, Beutel G, Hapke M, Sauer MG, Laudanna C, Hogg N, Vestweber D, Wollert KC,. 2011. GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice. Nat Med 17: 581-588.
39. Kireeva ML, Latinkic BV, Kolesnikova TV, Chen CC, Yang GP, Abler AS, Lau LF,. 1997. Cyr61 and Fisp12 are both ECM-associated signaling molecules: Activities, metabolism, and localization during development. Exp Cell Res 233: 63-77.
40. Kondo S, Kubota S, Shimo T, Nishida T, Yosimichi G, Eguchi T, Sugahara T, Takigawa M,. 2002. Connective tissue growth factor increased by hypoxia may initiate angiogenesis in collaboration with matrix metalloproteinases. Carcinogenesis 23: 769-776.
41. Kular L, Pakradouni J, Kitabgi P, Laurent M, Martinerie C,. 2011. The CCN family: A new class of inflammation modulators ? Biochimie 93: 377-388.
42. Kumar CC,. 2003. Integrin alpha v beta 3 as a therapeutic target for blocking tumor-induced angiogenesis. Curr Drug Targets 4: 123-131.
43. Lambert JR, Kelly JA, Shim M, Huffer WE, Nordeen SK, Baek SJ, Eling TE, Lucia MS,. 2006. Prostate derived factor in human prostate cancer cells: Gene induction by vitamin D via a p53-dependent mechanism and inhibition of prostate cancer cell growth. J Cell Physiol 208: 566-574.
44. Lau LF, Lam SC,. 1999. The CCN family of angiogenic regulators: The integrin connection. Exp Cell Res 248: 44-57.
45. Li PX, Wong J, Ayed A, Ngo D, Brade AM, Arrowsmith C, Austin RC, Klamut HJ,. 2000. Placental transforming growth factor-beta is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression. J Biol Chem 275: 20127-20135.
46. Lin CG, Leu SJ, Chen N, Tebeau CM, Lin SX, Yeung CY, Lau LF,. 2003. CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family. J Biol Chem 278: 24200-24208.
47. Lind L, Wallentin L, Kempf T, Tapken H, Quint A, Lindahl B, Olofsson S, Venge P, Larsson A, Hulthe J, Elmgren A, Wollert KC,. 2009. Growth- differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: Results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study. Eur Heart J 30: 2346-2353.
48. Lindmark F, Zheng SL, Wiklund F, Bensen J, Balter KA, Chang B, Hedelin M, Clark J, Stattin P, Meyers DA, Adami HO, Isaacs W, Gronberg H, Xu J,. 2004. H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer. J Natl Cancer Inst 96: 1248-1254.
49. Martinez JM, Sali T, Okazaki R, Anna C, Hollingshead M, Hose C, Monks A, Walker NJ, Baek SJ, Eling TE,. 2006. Drug-induced expression of nonsteroidal anti-inflammatory drug-activated gene/macrophage inhibitory cytokine-1/prostate- derived factor, a putative tumor suppressor, inhibits tumor growth. J Pharmacol Exp Ther 318: 899-906.
50. McCabe NP, De S, Vasanji A, Brainard J, Byzova TV,. 2007. Prostate cancer specific integrin alphavbeta3 modulates bone metastatic growth and tissue remodeling. Oncogene 26: 6238-6243.
51. Mercurio S, Latinkic B, Itasaki N, Krumlauf R, Smith JC,. 2004. Connective-tissue growth factor modulates WNT signalling and interacts with the WNT receptor complex. Development 131: 2137-2147.
52. Morrison BL, Jose CC, Cutler ML,. 2010. Connective tissue growth factor (CTGF/CCN2) enhances lactogenic differentiation of mammary epithelial cells via integrin-mediated cell adhesion. BMC Cell Biol 11: 35.
53. Mulgrew K, Kinneer K, Yao XT, Ward BK, Damschroder MM, Walsh B, Mao SY, Gao C, Kiener PA, Coats S, Kinch MS, Tice DA,. 2006. Direct targeting of alphavbeta3 integrin on tumor cells with a monoclonal antibody, Abegrin. Mol Cancer Ther 5: 3122-3129.
54. Nemeth JA, Cher ML, Zhou Z, Mullins C, Bhagat S, Trikha M,. 2003. Inhibition of alpha(v)beta3 integrin reduces angiogenesis, bone turnover, and tumor cell proliferation in experimental prostate cancer bone metastases. Clin Exp Metastasis 20: 413-420.
55. Orr AW, Murphy-Ullrich JE,. 2004. Regulation of endothelial cell function by FAK and PYK2. Front Biosci 9: 1254-1266.
56. Paralkar VM, Vail AL, Grasser WA, Brown TA, Xu H, Vukicevic S, Ke HZ, Qi H, Owen TA, Thompson DD,. 1998. Cloning and characterization of a novel member of the transforming growth factor-beta/bone morphogenetic protein family. J Biol Chem 273: 13760-13767.
57. Perbal B,. 2004. CCN proteins: Multifunctional signalling regulators. Lancet 363: 62-64.
58. Pi L, Shenoy AK, Liu J, Kim S, Nelson N, Xia H, Hauswirth WW, Petersen BE, Schultz GS, Scott EW,. 2012. CCN2/CTGF regulates neovessel formation via targeting structurally conserved cystine knot motifs in multiple angiogenic regulators. FASEB J 26: 3365-3379.
59. Reardon DA, Fink KL, Mikkelsen T, Cloughesy TF, O'Neill A, Plotkin S, Glantz M, Ravin P, Raizer JJ, Rich KM, Schiff D, Shapiro WR, Burdette-Radoux S, Dropcho EJ, Wittemer SM, Nippgen J, Picard M, Nabors LB,. 2008. Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme. J Clin Oncol 26: 5610-5617.
60. Russell TD, Palmer CA, Orlicky DJ, Fischer A, Rudolph MC, Neville MC, McManaman JL,. 2007. Cytoplasmic lipid droplet accumulation in developing mammary epithelial cells: Roles of adipophilin and lipid metabolism. J Lipid Res 48: 1463-1475.
61. Sabbah M, Emami S, Redeuilh G, Julien S, Prevost G, Zimber A, Ouelaa R, Bracke M, De Wever O, Gespach C,. 2008. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers. Drug Resist Updat 11: 123-151.
62. Schneider JG, Amend SR, Weilbaecher KN,. 2011. Integrins and bone metastasis: Integrating tumor cell and stromal cell interactions. Bone 48: 54-65.
63. Schober JM, Chen N, Grzeszkiewicz TM, Jovanovic I, Emeson EE, Ugarova TP, Ye RD, Lau LF, Lam SC,. 2002. Identification of integrin alpha(M)beta(2) as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): Immediate-early gene products expressed in atherosclerotic lesions. Blood 99: 4457-4465.
64. Selander KS, Brown DA, Sequeiros GB, Hunter M, Desmond R, Parpala T, Risteli J, Breit SN, Jukkola-Vuorinen A,. 2007. Serum macrophage inhibitory cytokine-1 concentrations correlate with the presence of prostate cancer bone metastases. Cancer Epidemiol Biomarkers Prev 16: 532-537.
65. Senapati S, Rachagani S, Chaudhary K, Johansson SL, Singh RK, Batra SK,. 2010. Overexpression of macrophage inhibitory cytokine-1 induces metastasis of human prostate cancer cells through the FAK-RhoA signaling pathway. Oncogene 29: 1293-1302.
66. Shimo T, Nakanishi T, Nishida T, Asano M, Kanyama M, Kuboki T, Tamatani T, Tezuka K, Takemura M, Matsumura T, Takigawa M,. 1999. Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo. J Biochem 126: 137-145.
67. Shimo T, Kubota S, Kondo S, Nakanishi T, Sasaki A, Mese H, Matsumura T, Takigawa M,. 2001a. Connective tissue growth factor as a major angiogenic agent that is induced by hypoxia in a human breast cancer cell line. Cancer Lett 174: 57-64.
68. Shimo T, Nakanishi T, Nishida T, Asano M, Sasaki A, Kanyama M, Kuboki T, Matsumura T, Takigawa M,. 2001b. Involvement of CTGF, a hypertrophic chondrocyte-specific gene product, in tumor angiogenesis. Oncology 61: 315-322.
69. Song H, Yin D, Liu Z,. 2012. " GDF-15 promotes angiogenesis through modulating p53/HIF-1alpha signaling pathway in hypoxic human umbilical vein endothelial cells. " Mol Biol Rep 39 (4): 4017-4022.
70. Sun LC, Luo J, Mackey LV, Fuselier JA, Coy DH,. 2007. A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9. Cancer Lett 246: 157-166.
71. Tabatabai G, Weller M, Nabors B, Picard M, Reardon D, Mikkelsen T, Ruegg C, Stupp R,. 2010. Targeting integrins in malignant glioma. Target Oncol 5: 175-181.
72. Tan TW, Lai CH, Huang CY, Yang WH, Chen HT, Hsu HC, Fong YC, Tang CH,. 2009. CTGF enhances migration and MMP-13 up-regulation via alphavbeta3 integrin, FAK, ERK, and NF-kappaB-dependent pathway in human chondrosarcoma cells. J Cell Biochem 107: 345-356.
73. Thomas R, True LD, Lange PH, Vessella RL,. 2001. Placental bone morphogenetic protein (PLAB) gene expression in normal, pre-malignant and malignant human prostate: Relation to tumor development and progression. Int J Cancer 93: 47-52.
74. Wang X, Kingsley PJ, Marnett LJ, Eling TE,. 2011. The role of NAG-1/GDF15 in the inhibition of intestinal polyps in APC/Min mice by sulindac. Cancer Prev Res (Phila) 4: 150-160.
75. Wary KK, Kohler EE, Chatterjee I,. 2012. Focal adhesion kinase regulation of neovascularization. Microvasc Res 83: 64-70.
76. Yang F, Tuxhorn JA, Ressler SJ, McAlhany SJ, Dang TD, Rowley DR,. 2005. Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. Cancer Res 65: 8887-8895.
77. Zebda N, Dubrovskyi O, Birukov KG,. 2012. Focal adhesion kinase regulation of mechanotransduction and its impact on endothelial cell functions. Microvasc Res 83: 71-81.
78. Zuo GW, Kohls CD, He BC, Chen L, Zhang W, Shi Q, Zhang BQ, Kang Q, Luo J, Luo X, Wagner ER, Kim SH, Restegar F, Haydon RC, Deng ZL, Luu HH, He TC, Luo Q,. 2010. The CCN proteins: Important signaling mediators in stem cell differentiation and tumorigenesis. Histol Histopathol 25: 795-806.